NDC 72162-1345 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC72162-1345

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA207276
Marketed since
October 25, 2017
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (9)

Package NDCDescriptionSince
72162-1345-0120 TABLET in 1 BOTTLE (72162-1345-0)Apr 22, 2024
72162-1345-260 TABLET in 1 BOTTLE (72162-1345-2)Apr 22, 2024
72162-1345-330 TABLET in 1 BOTTLE (72162-1345-3)Apr 22, 2024
72162-1345-420 TABLET in 1 BOTTLE (72162-1345-4)Apr 22, 2024
72162-1345-57 TABLET in 1 BOTTLE (72162-1345-5)Apr 22, 2024
72162-1345-628 TABLET in 1 BOTTLE (72162-1345-6)Apr 22, 2024
72162-1345-71 TABLET in 1 BOTTLE (72162-1345-7)Apr 22, 2024
72162-1345-812 TABLET in 1 BOTTLE (72162-1345-8)Apr 22, 2024
72162-1345-914 TABLET in 1 BOTTLE (72162-1345-9)Apr 22, 2024

Other Buprenorphine products